Juliesta Sylvester

Managing Director

Juliesta’s Bio

Juliesta advises Health-Tech companies on M&A and strategic financing transactions.

Prior to joining WCP, Juliesta was Head of the Global Data and Innovation divisions at Diaceutics, where she built, priced, and brought to market a suite of data products and analytical services that transformed the privately-owned consulting company into a publicly traded technology company on the LSE. She brings 20 years of combined experience brokering healthcare data transactions, leading data analytics startups, and partnering with top-10 biotechnology and pharmaceutical companies on intellectual property and product development. Juliesta has deep expertise in diagnostic and genomics technologies.

Some of the product developments that Juliesta led include a cloud-based, HIPAA- and GDPR-compliant clinical data platform for Pharma, a multi-omics integration SaaS for providers, a statistical confidence tool for diagnostics, high-throughput drug development screens, and R&D partnerships with Janssen, Merck, Luminex, and SoluLink. For 7 years, Juliesta has also co-invested with Beacon Value Partners in Cambridge, MA.

Juliesta has a B.A. and Ph.D. in Biochemistry and Molecular Biology, both from the University of Chicago. Her postdoctoral projects were at the Massachusetts Institute of Technology (MIT) and The Scripps Research Institute (TSRI).

Juliesta’s Focus

Digital Health

Juliesta’s Thought Leadership

Let The IPO’s Begin: 2019 Trends in Digital Health by Vini Jolly

WCP Proudly Releases the Inaugural Healthcare Report “State of Digital Health”

WCP Insights Blog: AI and Healthcare (Part 1: Visual) by Vini Jolly

WCP Insights Blog: The Promise of Personalized Medicine by Vini Jolly

Patents

Methods for accurately measuring enzyme activity.

Method for quantitative analysis of complex proteomic data.

Modified template-independent enzymes for polydexynucleotide synthesis.

Book

The Ethical Dilemma: Insights from Shakespeare, Milton, and McNamara. PhD Publishing, 1995, 107 pages. ISBN 0932010725, 9780932010728

Peer-Reviewed Scientific Articles

Zhou, G., Khan, F., Dai, Q., Sylvester, J.E., Kron, S.J. (2012). Photocleavable peptide-oligonucleotide conjugates for protein kinase assays by MALDI-TOF MS. Mol. BioSyst., 8:2395-404.

Sylvester, J.E., Bray, T.S., Kron, S.J. (2012). Annotator: Postprocessing software for generating function-based signatures from quantitative mass spectrometry. J. Proteome Res., 11:1521-36.

Zhou, G., Sylvester, J.E., Wu, D., Veach, D., Kron. S.J. (2011). A magnetic bead-based protein kinase assay with dual detection techniques. Anal. Biochem., 408: 5-11.

Sylvester, J.E., Kron, S.J., (2010). A bead-based activity screen for small-molecule inhibitors of signal transduction in chronic myelogenous leukemia. Mol. Cancer Ther., 9:1469-81.

Wu, D., Sylvester, J.E., Parker, L.L., Zhou G., Kron, S.J. (2010). Peptide reporters of kinase activity in whole cell lysates,. Biopolymers, 94:475-86.

Walsh, S.T., Sylvester, J.E., Kossiakoff, A.A. (2004). The high- and low-affinity receptor binding sites of growth hormone are allosterically coupled. Proc Natl Acad Sci USA, 101:17078-83.

Colombe, J.B., Sylvester, J.E., Block, J., Ulinksi, P.S. (2004). Subpial and stellate cells: two populations of interneurons in turtle visual cortex. J. Comp. Neurol. 471: 333-51.

Walsh, S.T., Jevitts, L.M., Sylvester, J.E., Kossiakoff, A.A. (2003). Site2 binding energetics of the regulatory step of growth hormoneinduced receptor homodimerization. Prot. Sci. 12:1960-70

Investor Relations

Sylvester, J.E. (2014). A faster and cheaper strategy for drug discovery. Michelson Medical Research Foundation.
Sylvester, J.E., (2014). Hepatitis C: Throwing light on the shadow epidemic. Michelson Medical Research Foundation.
Sylvester, J.E. (2014). Breast milk contains beneficial bacteria. Michelson Medical Research Foundation.
Sylvester, J.E. (2014). Spinal cord injury: Critical Research from PVA. Michelson Medical Research Foundation.
Sylvester, J.E. (2015). Biotech L.A. #1: Biotechnology Research Hub. Michelson Medical Research Foundation.
Sylvester, J.E. (2015). Biotech L.A. #2: Convergent Research Ecosystem. Michelson Medical Research Foundation.
Sylvester, J.E. (2015). Biotech L.A. #3: Cultivating Biotech in Los Angeles. Michelson Medical Research Foundation.

Enanta and AbbVie’s ABT-450 Likely to Receive FDA Approval. Seeking Alpha 2014.

Artificial Intelligence and Machine Learning, by Robin Robinson. PharmaVOICE. May 2018

Diaceutics, Intel, and Lenovo advanced patient care using AI and workstations powered by Intel Xeon Scalable processors.

Transactions

WCP acted as exclusive financial advisor to KRT Marketing in its acquisition by Recruitics. KRT Marketing is a West Coast based data-driven recruitment marketing agency. Recruitics is an East Coast based agency the makes it easy for leading brands to attract and hire great talent. As pioneers in the space, Recruitics revolutionized recruitment advertising in 2012 by introducing the first recruitment marketing analytics and optimization platform. By acquiring another rapidly growing and innovative agency, Recruitics strengthened its position as the leading provider of talent attraction solutions to the Fortune 100.

Valencell, the leading innovator in wearable biometric sensor technology, and Sonion, the global leader in micro acoustic and micro mechanical technologies and solutions for hearing instruments and specialty earphones, today announced a strategic partnership that will expand the boundaries for the use of biometric sensors in the ear. As part of the partnership, Sonion has made a strategic investment in Valencell, making Sonion a significant shareholder in Valencell Inc. WCP acted as exclusive advisor to Valencell for this transaction.